Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3CRRN9
Wed, 30.04.2025
Cherry SE
Munich, 30 April 2025 – Implications of the restructuring concept on reportable elements of the 2024 annual report have led to a postponement of its publication
In the context of the audit of Cherry SE’s 2024 annual financial statements, the publication date of the annual report has been rescheduled. It was originally planned for publication on 30 [ … ]
Tue, 29.04.2025
Cherry SE
Munich, 29 April 2025 – Cherry SE announced preliminary financial performance indicators for the first quarter of 2025. Group revenue and adjusted Group EBITDA margin are in line with budget and, as planned, below the prior-year level, fully in line with the company’s expectations.
Group sales in the first quarter of 2025 amounted to EUR 25.3 mill [ … ]
Mon, 28.04.2025
Cherry SE
Munich, 28 April 2024 – Based on preliminary and unaudited figures, the Management Board of Cherry SE expects Group revenue of approximately EUR 25.3 million in the first quarter of 2025 (Q1 2024: EUR 30.3 million) and an adjusted Group EBITDA margin* of -8.0% (Q1 2024: 2.8%).
Group revenue for the first quarter of the current fiscal year is appro [ … ]
Tue, 22.04.2025
Cherry SE
Agreement reached with UniCredit on the extension of financing based on a restructuring concept; implementation of restructuring measures including workforce reduction and relocation of switch production to China; forecast for the 2025 fiscal year
Munich, 22 April 2025 – Cherry SE today entered into an agreement with UniCredit Bank GmbH regarding [ … ]
Fri, 11.04.2025
Cherry SE
Munich, 11 April 2025 – While preparing the consolidated financial statements for fiscal year 2024 and in close coordination with its auditor, Cherry SE has recognized impairments on assets totaling EUR 28.6 million. This amount includes EUR 7.9 million related to goodwill, EUR 15.8 million related to other non-current assets, and EUR 4.9 million r [ … ]
Mon, 31.03.2025
Cherry SE
Munich, 31 March 2025 – With gematik’s provider approval for its SmartLink technology, CHERRY Digital Health has achieved a significant milestone in advancing digital healthcare. This solution facilitates the secure and user-friendly dispensing of e-prescriptions via the electronic health card (eGK) using NFC-enabled smartphones, ensuring seamless, [ … ]
Thu, 27.02.2025
Cherry SE
Munich, 27 February 2025 – Cherry SE announces additional preliminary group key figures, along with divisional sales and results for the last fiscal year.
As previously announced on 11 February 2025, Cherry SE concluded the 2024 financial year with a consolidated group revenue of approximately EUR 110 million and an adjusted EBITDA margin of aroun [ … ]
Mon, 17.02.2025
Cherry SE
Munich, 17 February 2025 – Charlotte Johs steps down from the Supervisory Board of Cherry SE as she intends to join the Board of a Danish Company.
Cherry SE announced today that Charlotte Johs has decided to step down from her position on the Supervisory Board of Cherry SE, effective 28 February 2025. Ms. Johs has been nominated and intends to ass [ … ]
Wed, 12.02.2025
Cherry SE
Munich, 12 February 2025 - Dr. Philip Groth will take over the position of Managing Director of Cherry Digital Health GmbH, a subsidiary of Cherry SE, on March 1, 2025.
On 1 March 2025, Dr. Groth, an experienced manager in the pharma and health tech space with a focus on leadership, business growth, governance and strategic transformation will tak [ … ]
Tue, 11.02.2025
Cherry SE
Munich, 11 February 2025 - Starting in 2025, Cherry SE will discontinue quarterly forecasts and instead prioritize a reliable full-year outlook.
Given the volatility of the capital markets and business environment, the Management Board has decided to discontinue quarterly forecasts in 2025 and instead focus on a reliable full-year outlook. This de [ … ]